Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Helg

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The British Journal of Dermatology|January 22, 2003
An unusual form of primary systemic amyloidosis: amyloid elastosis: report of a case treated by haematopoietic cell transplantationG Vecchietti, I Masouyé, D Salomon, et al.
Bone Marrow Transplantation|December 1, 1994
Kaposi's sarcoma following allogeneic bone marrow transplantationC Helg, M Adatto, D Salomon, et al.
Bone Marrow Transplantation|June 1, 1993
Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graftR Miralbell, B Chapuis, P Nouet, et al.
Blood|September 9, 2000
Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activityE Roux, F Dumont-Girard, M Starobinski, et al.
Bone Marrow Transplantation|August 26, 1998
Characterisation of the cytotoxic alloresponse of cord bloodC Barbey, O Irion, C Helg, et al.
Transplantation|June 27, 1997
Recognition of major histoincompatibilities after transplantation with marrow from HLA closely matched donorsN Rufer, C Helg, J M Tiercy, et al.
European Journal of Haematology|October 26, 1999
BCR-negative chronic myeloid leukemia in relapse after bone marrow transplantation is susceptible to remission induction by donor lymphocyte infusionsP Y Lovey, R Darbellay, C Cabrol, et al.
Bone Marrow Transplantation|January 1, 1993
Characterization of pretransplant CTL activity in "perfectly matched" unrelated bone marrow donor/recipient combinationsN Rufer, J M Tiercy, D Speiser, et al.
Bone Marrow Transplantation|August 20, 2008
Quality of life and social integration after allogeneic hematopoietic SCTS Bieri, E Roosnek, C Helg, et al.
British Journal of Cancer|May 11, 2006
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphomaF Buchegger, C Antonescu, A Bischof Delaloye, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The British Journal of Dermatology|January 22, 2003
An unusual form of primary systemic amyloidosis: amyloid elastosis: report of a case treated by haematopoietic cell transplantationG Vecchietti, I Masouyé, D Salomon, et al.
Bone Marrow Transplantation|December 1, 1994
Kaposi's sarcoma following allogeneic bone marrow transplantationC Helg, M Adatto, D Salomon, et al.
Bone Marrow Transplantation|June 1, 1993
Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graftR Miralbell, B Chapuis, P Nouet, et al.
Blood|September 9, 2000
Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activityE Roux, F Dumont-Girard, M Starobinski, et al.
Bone Marrow Transplantation|August 26, 1998
Characterisation of the cytotoxic alloresponse of cord bloodC Barbey, O Irion, C Helg, et al.
Transplantation|June 27, 1997
Recognition of major histoincompatibilities after transplantation with marrow from HLA closely matched donorsN Rufer, C Helg, J M Tiercy, et al.
European Journal of Haematology|October 26, 1999
BCR-negative chronic myeloid leukemia in relapse after bone marrow transplantation is susceptible to remission induction by donor lymphocyte infusionsP Y Lovey, R Darbellay, C Cabrol, et al.
Bone Marrow Transplantation|January 1, 1993
Characterization of pretransplant CTL activity in "perfectly matched" unrelated bone marrow donor/recipient combinationsN Rufer, J M Tiercy, D Speiser, et al.
Bone Marrow Transplantation|August 20, 2008
Quality of life and social integration after allogeneic hematopoietic SCTS Bieri, E Roosnek, C Helg, et al.
British Journal of Cancer|May 11, 2006
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphomaF Buchegger, C Antonescu, A Bischof Delaloye, et al.
Pageof 6